Search results
You searched for:
Found 1,518 results
Sorting options:
Date: 01/01/2026 Location: Other
This medicinal cannabis course focuses on inflammatory bowel disease – Crohn’s disease and ulcerative colitis. As the incidence of inflammatory bowel diseases rises, medicinal cannabis has been increasingly researched for employment in these diseases, particularly in the symptomatic relief from abdominal pain, nausea and diarrhoea, and an improved sense of well-being. As with many chronic disorders, lifelong therapy is required. Pharmacological load in these conditions can be considerable with unacceptable side effects and only moderate control of symptoms. Given these factors, there is a role for medicinal cannabis; not curative or as a substitute for conventional medications aimed at altering the underlying disease, but for symptom management and improved quality of life. The course takes the form of four case studies, which examine different methods of approaching medicinal cannabis therapy given the relative paucity of specific recommendations for usage. The cases represent four inflammatory bowel states and guide the practitioner through negotiating what is in essence, a very personalised medicine.
4.5 Educational activity hours
6 Performance review hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
This men’s health course focuses on lifestyle choices including smoking and alcohol and the health impacts of these behaviours on health and wellbeing. The course outlines the impact of obesity and the sedentary lifestyle and how these increase the risk of elevated blood lipids, coronary artery disease and peripheral vascular disease. Statistics on insurance claims highlight the health and monetary costs of poorer lifestyle choices. Unit one explores how this behaviour can be prevented and reduce health costs. Statistics on smoking, alcohol and methamphetamine use are presented including the related illnesses that may be caused by these lifestyle choices. Four case studies are profiled including how a medical practitioner can work with patients to encourage positive lifestyle choices. Information and tools on the best approaches to support lifestyle choices are a feature of this course.
4.5 Educational activity hours
6 Performance review hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
This medicinal cannabis course focuses on ASD – Autism, ADHD, OCD and Tourettes. The course considers the role of medicinal cannabis in the treatment of obsessive-compulsive disorder (OCD), attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD) and Tourette's syndrome - all of which are encompassed in a wide spectrum of disease states. These neuropsychiatric disorders present a complicated diagnostic area where certain disease states may be comorbidities of another. All conditions may exist concurrently with various ratios of each. In each condition, there is some form of dysregulation of the endocannabinoid system (ECS). Cannabis medicine when used to stimulate and support the ECS may facilitate better neurological functioning. Given that these conditions usually commence in childhood, the course discusses protocols and ethical considerations for treating the paediatric population with cannabinoid medicines. Case studies highlight the caution and flexibility required to achieve acceptable results with this individualised therapy, including careful, stepwise titration and monitoring with THC, consideration of different chemovars, and frequent communication with patients and carers.
4 Educational activity hours
6 Performance review hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
This medicinal cannabis course focuses on diabetes, glaucoma and hypertension. The course examines the role of medicinal cannabis in type 1 and type 2 diabetes, metabolic syndrome, the comorbidity of glaucoma (secondary to retinopathy), and hypertension, which accelerates the risk and course of cardiovascular and other comorbidities. The course discusses salient evidence and research findings such as the effects of recreational cannabis use in diabetes, the uniquely diverse properties of THCV, and the anti-diabetic effects of Rimonabant. THC, CBD, and minor cannabinoids such as THCV, may be beneficial in the management of diabetes, but they should be used adjunctively with conventional treatments. Cannabinoids may also treat a raft of diabetes-associated conditions such as hypertension and retinopathy. Case studies explore the use of medicinal cannabis for symptoms such as neuropathic pain, insomnia and restless leg syndrome, as well as possible benefits such as changes in weight, blood sugar and blood pressure.
4 Educational activity hours
6 Performance review hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
This medicinal cannabis course focuses on women’s health issues of endometriosis, PMS and osteoporosis. It examines the endocannabinoid system in the female reproductive tissues and the potential role for medicinal cannabis in women’s health. The symptoms of endometriosis and premenstrual syndrome may be extreme and debilitating and significantly impact the quality of life. Conventional treatments for these conditions are limited with sometimes severe side effects making medicinal cannabis treatment a reasonable option. Osteoporosis, conversely, may be asymptomic until fractures profoundly impact the morbidity and mortality of the patient. The course considers research indicating that endocannabinoid dysregulation is involved in each of these disorders. The potential for activation or suppression of certain receptors with cannabinoids may support healthy endocannabinoid system homeostatic function. THC and CBD may play a role in modulating pain, reducing inflammation, regulating immune function, rebalancing endocannabinoid tone, enhancing bone healing and regeneration, and treating age-related and hormone deficiency-related bone loss and osteoporosis. The course guides the practitioner through choosing a cannabis product for these conditions.
4 Educational activity hours
6 Performance review hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
This medicinal cannabis course focuses on COPD, asthma, eczema, psoriasis and skin conditions. It discusses the potential for medicinal cannabis (particularly CBD) to treat skin disorders - particularly those with an inflammatory component. It examines conditions such as eczema, psoriasis, fibrotic disorders (scleroderma), and non-melanoma skin cancer. The endocannabinoid system of the skin maintains cutaneous homeostasis and plays an important role in the regulation of the physiology of the skin and the immune system. The dysregulation of this system is linked to a wide variety of dermatological disorders. Research suggests that modulation of the endocannabinoid system could be a promising strategy for the treatment of skin disorders. The course explores the relatively new area of cannabis support for pulmonary conditions given the bronchodilatory effect of THC and the anti-inflammatory effect of CBD. There is also the potential for endocannabinoid system-mediated immune modulation and anti-inflammatory responses. The course offers guidelines for the treatment of skin and pulmonary conditions with medicinal cannabis including the specific cannabis formulations for topical and inhaled administration.
4.5 Educational activity hours
6 Performance review hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
With Voluntary Assisted Dying laws implementation rolling out across the remaining states in 2023, deciding to participate as a medical practitioner in the VAD process requires careful consideration. This activity aims to provide members with information on the obligations, requirements and processes of Voluntary Assisted Dying Laws. This webinar aims to provide members with information to assist in the decision-making process, and explores many aspects of the VAD process
1.5 Educational activity hours
0.5 Performance review hour
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
In this recorded webinar, MDA National’s Medicare Committee members discuss common billing questions on the following topics: chronic disease management, rules around bulk billing, co-claiming of MBS items, telehealth, what can’t be billed to Medicare, monitoring what is billed to your provider number and the audit process.
1 Educational activity hour
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
The changes to the Fair Work Act impact areas such as job security, work conditions and Enterprise Agreements. It is important for all employers and employees to be across these changes to ensure they are aware of their obligations and rights as employers and/or employees. This 1.5hr session targets members who own a practice or are responsible for the management of staff contracts and related matters. Practice Managers may also find this session helpful.
0.5 Educational activity hour
1 Performance review hour
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
While it may assist the doctor in medical note taking, AI software does not replace the doctor’s professional obligations to ensure records made are accurate, up to date and securely managed. Tierney et al (2024) noted that “careful and ongoing attention must be paid to ensure that the technology supports clinicians while also optimizing ambient AI scribe output for accuracy, relevance, and alignment in the physician–patient relationship”. Medical record keeping is fundamental to supporting the delivery high quality and safe patient care. Ahpra and Medicare both outline requirements for medical records which are to be adhered to. The TGA also provides information for software manufacturers about the regulation of AI. This activity considers AI technology, including the benefits, barriers and risks in relation to medical records.
1.5 Educational activity hours
Professionalism
Ethical practice